Skip to main content

Advertisement

SpringerLink
Log in

Increased risk of death in pediatric and adult patients with ESRD secondary to lupus

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that can cause significant kidney disease. Our goal was to assess the relative mortality risk associated with SLE in pediatric and adult populations with end-stage renal disease (ESRD) maintained on hemodialysis (HD). We performed Kaplan–Meier survival analysis from data collected by the United States Renal Data System (USRDS) in strata of pediatric and adult patients. This file includes data on all Medicare-reimbursed renal replacement patients. Cox proportional hazard models were used to assess mortality after adjusting for race and gender. Subjects were censored at transplantation or at end of follow-up. Pediatric patients with ESRD secondary to SLE had a 2-fold increased risk of death compared with other pediatric patients with ESRD (hazard ratio [HR]: 2.4, 95% confidence interval [CI]: 1.5–3.7). Adult patients with ESRD secondary to SLE were also at increased risk of death compared with other adult patients (HR: 1.7, 95% CI: 1.2–2.7). The most common causes of death in both pediatric and adult patients with SLE were cardiovascular disease and cardiac arrest. Our study demonstrates that there is a significant increase in mortality secondary to cardiovascular disease in pediatric and adult patients with ESRD secondary to SLE. Patients with ESRD secondary to SLE may need aggressive monitoring for traditional risk factors for atherosclerosis and the diagnosis of SLE alone may be an independent risk factor for death in patients with ESRD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Stichweh D, Arce E, Pascual V (2004) Update on pediatric systemic lupus erythematosus. Curr Opin Rheumatol 16:577–587

    Article  CAS  PubMed  Google Scholar 

  2. Jimenez S, Cervera R, Font J, Ingelmo M (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25:3–12

    Article  PubMed  Google Scholar 

  3. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, Liang MH, Kremers HM, Mayes MD, Merkel PA, Pillemer SR, Reveille JD, Stone JH, Workgroup National Arthritis Data (2008) Estimates of the prevalence of arthritis and other rheumatic conditions in the united states. I. Arthritis Rheum 58:15–25

    Article  PubMed  Google Scholar 

  4. Bogdanovic R, Nikolic V, Pasic S, Dimitrijevic J, Lipkovska-Markovic J, Eric-Marinkovic J, Ognjanovic M, Minic A, Stajic N (2004) Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr Nephrol 19:36–44

    Article  PubMed  Google Scholar 

  5. Elliot V, Cairns T, Cook HT (2006) Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. Am J Kidney Dis 47:184–190

    Article  PubMed  Google Scholar 

  6. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A, Gladman D, Urowitz M, Hebert D, Silverman E (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635–2642

    PubMed  Google Scholar 

  7. Rood MJ, ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, Huizinga TW (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226

    Article  CAS  PubMed  Google Scholar 

  8. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M, International Society of Nephrology Working Group on the Classification of Lupus Nephritis, Renal Pathology Society Working Group on the Classification of Lupus Nephritis (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530

    Article  PubMed  Google Scholar 

  9. US Renal Data System, USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2004) National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases

  10. Bartosh SM, Fine RN, Sullivan EK (2001) Outcome after transplantation of young patients with systemic lupus erythematosus: a report of the North American Pediatric Renal Transplant Cooperative Study. Transplantation 72:973–978

    Article  CAS  PubMed  Google Scholar 

  11. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, D'Agostino RB, Kuller LH (1997) Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:408–415

    CAS  PubMed  Google Scholar 

  12. Van Doornum S, McColl G, Wicks IP (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 46:862–873

    Article  PubMed  Google Scholar 

  13. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:2331–2337

    Article  CAS  PubMed  Google Scholar 

  14. Gazarian M, Feldman BM, Benson LN, Gilday DL, Laxer RM, Silverman ED (1998) Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J Pediatr 132:109–116

    Article  CAS  PubMed  Google Scholar 

  15. Schanberg LE, Sandborg C, Barnhart HX, Ardoin SP, Yow E, Evans GW, Mieszkalski KL, Ilowite NT, Eberhard A, Levy DM, Kimura Y, von Scheven E, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung L, Soep JB, Reed A, Atherosclerosis Prevention in Pediatric Lupus Erythematosus Investigators (2009) Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the Atherosclerosis Prevention in Pediatric Lupus Erythematosus Cohort. Arthritis Rheum 60:1496–1507

    Article  PubMed  Google Scholar 

  16. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie JE, Tracy RP, Kuller LH (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42:51–60

    Article  CAS  PubMed  Google Scholar 

  17. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843

    Article  CAS  PubMed  Google Scholar 

  18. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, D'Agostino RB, O'Donnell CJ (2002) Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 22:1662–1667

    Article  CAS  PubMed  Google Scholar 

  19. Mangge H, Hubmann H, Pilz S, Schauenstein K, Renner W, Marz W (2004) Beyond cholesterol–inflammatory cytokines, the key mediators in atherosclerosis. Clin Chem Lab Med 42:467–474

    Article  CAS  PubMed  Google Scholar 

  20. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149–2153

    CAS  PubMed  Google Scholar 

  21. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2399–2406

    Article  CAS  PubMed  Google Scholar 

  22. Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349:2407–2415

    Article  CAS  PubMed  Google Scholar 

  23. Petri M, Perez-Gutthann S, Spence D, Hochberg MC (1992) Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 93:513–519

    Article  CAS  PubMed  Google Scholar 

  24. Ilowite NT, Samuel P, Ginzler E, Jacobson MS (1988) Dyslipoproteinemia in pediatric systemic lupus erythematosus. Arthritis Rheum 31:859–863

    Article  CAS  PubMed  Google Scholar 

  25. Frostegard J (2002) Autoimmunity, oxidized LDL and cardiovascular disease. Autoimmun Rev 1:233–237

    Article  CAS  PubMed  Google Scholar 

  26. Posadas-Romero C, Torres-Tamayo M, Zamora-Gonzalez J, Aguilar-Herrera BE, Posadas-Sanchez R, Cardoso-Saldana G, Ladron de Guevara G, Solis-Vallejo E, El Hafidi M (2004) High insulin levels and increased low-density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus. Arthritis Rheum 50:160–165

    Article  CAS  PubMed  Google Scholar 

  27. Parekh RS, Zhang L, Fivush BA, Klag MJ (2005) Incidence of atherosclerosis by race in the dialysis morbidity and mortality study: a sample of the US ESRD population. J Am Soc Nephrol 16:1420–1426

    Article  PubMed  Google Scholar 

  28. Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, Powe NR, Coresh J, Klag MJ (2008) The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 74:1335–1342

    Article  CAS  PubMed  Google Scholar 

  29. Fong KY, Thumboo J, Koh ET, Chng HH, Leong KH, Koh WH, Howe HS, Leong KP, Lim B, Koh DR, Ng SC, Feng PH, Boey ML (1997) Systemic lupus erythematosus: initial manifestations and clinical features after 10 years of disease. Ann Acad Med Singapore 26:278–281

    CAS  PubMed  Google Scholar 

  30. Elliott JR, Manzi S (2009) Cardiovascular risk assessment and treatment in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 23:481–494

    Article  PubMed  Google Scholar 

  31. Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, Perani G, Martini A (2000) Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 43:1405–1409

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johns Hopkins University, 200 North Wolfe Street, Suite 2126, Baltimore, MD, 21205, USA

    Sangeeta Sule, Barbara Fivush & Alicia Neu

  2. Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    Susan Furth

Authors
  1. Sangeeta Sule
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Fivush
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alicia Neu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Susan Furth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sangeeta Sule.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sule, S., Fivush, B., Neu, A. et al. Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol 26, 93–98 (2011). https://doi.org/10.1007/s00467-010-1640-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-010-1640-9

Keywords

Search

Navigation